Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hyperparathyroidism, Primary × Cinacalcet × Clear all

Phase

Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperparathyroidism 2 Parathyroid Neoplasms 1 Neoplasm Metastasis 1 Hyperparathyroidism, Secondary 1 Hyperparathyroidism, Primary 1 Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00037518 2013-05-08

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Amgen

Phase 4 Completed

Hyperparathyroidism, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡